tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
SPRY
ARS Pharmaceuticals
RESEARCH TOOLSreports

ARS Pharmaceuticals (SPRY) Stock News & Sentiment

Compare
564 Followers
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
Premium
TipRanks Newswire
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
7d ago
CTMX
NSRX
ARS Pharmaceuticals Reports 2025 Results and neffy Growth
Premium
Company Announcements
ARS Pharmaceuticals Reports 2025 Results and neffy Growth
14d ago
8K
SPRY
ARS Pharmaceuticals: Buy Rating Reaffirmed on Improved Competitive Outlook After Aquestive’s Anaphylm Setback
Premium
Ratings
ARS Pharmaceuticals: Buy Rating Reaffirmed on Improved Competitive Outlook After Aquestive’s Anaphylm Setback
2M ago
SPRY
Regulatory Setbacks for Anaphylm Enhance ARS Pharmaceuticals’ Competitive Position and Support SPRY Buy Rating
Premium
Ratings
Regulatory Setbacks for Anaphylm Enhance ARS Pharmaceuticals’ Competitive Position and Support SPRY Buy Rating
2M ago
SPRY
ARS Pharmaceuticals: Strategic Positioning and Market Potential for Neffy Justifies Buy Rating
Premium
Ratings
ARS Pharmaceuticals: Strategic Positioning and Market Potential for Neffy Justifies Buy Rating
4M ago
SPRY
ARS Pharmaceuticals Reports Strong Q3 2025 Growth
Premium
Company Announcements
ARS Pharmaceuticals Reports Strong Q3 2025 Growth
4M ago
SPRY
Ars Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
Premium
Company Announcements
Ars Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
4M ago
SPRY
More SPRY News >

SPRY News on the Web

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), ARS Pharmaceuticals (SPRY) and CG Oncology, Inc. (CGON)
TipRanks News
Bullish
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY), BillionToOne, Inc. Class A (BLLN) and Praxis Precision Medicines (PRAX)
TipRanks News
Bullish
ARS Pharmaceuticals Inc (SPRY) Q4 2025 Earnings Call Highlights: Strong Market Entry and ...
GuruFocus News
Bullish
Q4 2025 ARS Pharmaceuticals Inc Earnings Call Transcript
GuruFocus News
Neutral
Midday Fly By: Hims & Hers reaches Novo deal, Live Nation settles with DOJ
TipRanks News
Bullish
Analysts Conflicted on These Healthcare Names: Hims & Hers Health (HIMS), ARS Pharmaceuticals (SPRY) and Revolution Medicines (RVMD)
TipRanks News
Bullish
ARS Pharmaceuticals (SPRY) Beats Earnings and Revenue Expectations
GuruFocus News
Bullish

News Score - Last 7 Days

Neutral
SPRY
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.5 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SPRY’s Media Buzz Sentiment?
1 articles about SPRY were published this week. In an average week, 3.5 articles are published.
    What is SPRY’s weekly average amount of articles?
    In an average week, 3.5 articles about SPRY are published.
      What is SPRY’s News Sentiment?
      100% of articles about SPRY were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        KHTRFKnight Therapeutics
        HYPRHyperfine
        KMTSKestra Medical Technologies Ltd.
        OVIDOvid Therapeutics
        PYPDPolyPid
        Showing the stocks with the most bullish news sentiment over the past week